arsenic trioxide has been researched along with Testicular Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Liu, T; Niu, T; Wang, L; Xie, LP; Zeng, K; Zou, XL | 1 |
| Beer, TM; Crawford, ED; Dreicer, R; Margolin, KA; Nichols, CR; Quinn, DI; Raghavan, D; Stephenson, WT; Tangen, CM | 1 |
1 trial(s) available for arsenic trioxide and Testicular Neoplasms
| Article | Year |
|---|---|
Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignancies.
Topics: Adult; Antineoplastic Agents; Arrhythmias, Cardiac; Arsenic Trioxide; Arsenicals; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Oxides; Pneumonia; Respiratory Distress Syndrome; Survival Rate; Testicular Neoplasms; Treatment Outcome | 2006 |
1 other study(ies) available for arsenic trioxide and Testicular Neoplasms
| Article | Year |
|---|---|
Acute promyelocytic leukemia with Flt3-TKD and WT1 mutations relapsing in a testicle and followed by systemic relapse.
Topics: Adult; Arsenic Trioxide; Arsenicals; Combined Modality Therapy; Daunorubicin; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Promyelocytic, Acute; Male; Neoplasm Recurrence, Local; Oxides; Salvage Therapy; Sarcoma, Myeloid; Testicular Neoplasms; Testis; Tretinoin; WT1 Proteins | 2013 |